表紙
市場調查報告書
商品編碼
975076

組織工程市場:按類型,按應用:全球機會分析和行業預測(2020-2027)

Tissue Engineering Market by Type, Application : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版日期: | 出版商: Allied Market Research | 英文 227 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2019年,全球組織工程市場規模為23.74億美元。從2020年到2027年,該市場預計將以14.2%的複合年增長率增長,到2027年將達到68.15億美元。

組織工程學是一個跨學科領域,將工程學和生命科學原理應用於恢復,維持或改善組織功能的生物替代品的開發。另外,該過程將細胞和生物分子與支架結合在一起。支架是模仿真實器官的人工或自然結構。

由於慢性病和外傷緊急情況的流行,對組織工程的相關意識增強以及潛在的管道產品,在預測期內,組織工程市場預計將顯著增長。此外,與新興經濟體對組織工程的認識提高相關的研發活動數量的增加有望促進市場增長。發達國家在組織工程和再生醫學領域正在採用技術進步,這將有助於擴大全球市場。此外,預計關鍵參與者對基於組織工程的治療方法的日益關注將在預測期內促進組織工程市場的增長。但是,嚴格的政府法規和高昂的治療費用有望阻礙市場的增長。

該報告對組織工程市場進行了調查,並概述了市場以及按類型,應用程序,區域和進入市場的公司概況的趨勢。

目錄

第1章簡介

第2章執行摘要

第3章市場情況

  • 市場定義和範圍
  • 主要發現
    • 主要投資口袋
    • 主要成功策略
  • 波特的五力分析
  • 2019年頂尖球員的排名
  • 市場動態
    • 促進因素
      • 器官移植中對組織工程的需求越來越大
      • 醫療器械技術的進步
      • 慢性病和外傷緊急情況的患病率增加
    • 抑制因素
      • 與組織工程產品相關的高成本
      • 與組織工程相關的障礙
    • 市場機會
      • 新興市場的增長機會
    • 影響分析
  • 腎臟和肝臟組織工程的市場信息
  • 市場概況:產品細分
    • 細胞療法
    • 基因療法
    • 小分子和生物製劑
  • COVID-19在組織工程市場中的影響分析

第4章組織工程市場:按類型

  • 概述
    • 市場規模和預測
  • 合成腳手架材料
    • 主要市場趨勢的增長因素和機遇
    • 市場規模和預測:按類型
      • 合成聚合物
      • 其他
    • 市場規模和預測:按地區
    • 市場分析:按國家
  • 生物支架材料
    • 主要市場趨勢的增長因素和機遇
    • 市場規模和預測:按類型
      • 膠原蛋白
      • 其他
    • 市場規模和預測:按地區
    • 市場分析:按國家
  • 其他
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測:按地區
    • 市場分析:按國家

第5章組織工程市場:按應用

  • 概述
    • 市場規模和預測
  • 骨科和肌肉骨骼
    • 市場規模和預測:按地區
    • 市場分析:按國家
  • 神經病學
    • 市場規模和預測:按地區
    • 市場分析:按國家
  • 心血管
    • 市場規模和預測:按地區
    • 市場分析:按國家
  • 皮膚和外皮
    • 市場規模和預測:按地區
    • 市場分析:按國家
  • 牙科
    • 市場規模和預測:按地區
    • 市場分析:按國家
  • 其他
    • 市場規模和預測:按地區
    • 市場分析:按國家

第6章組織工程市場:按地區

  • 概述
    • 市場規模和預測
  • 北美
    • 關鍵市場趨勢,關鍵增長因素和機遇
    • 市場規模和預測:按國家
      • 美國
      • 加拿大
      • 墨西哥
    • 北美市場規模和預測:按類型
    • 北美市場規模和預測:按應用
  • 歐洲
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測:按國家
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他
    • 歐洲市場規模和預測:按類型
    • 歐洲市場規模和預測:按應用
  • 亞太地區
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他
    • 亞太市場規模和預測:按類型
    • 亞太市場規模和預測:按用途
  • 拉美
    • 主要市場趨勢,增長因素和機遇
    • 市場規模和預測
      • 拉丁美洲
      • 中東和非洲
    • LAMEA市場規模和預測:按類型
    • LAMEA市場規模和預測:按應用

第7章公司簡介

  • ABBVIE INC. (ALLERGEN PLC.)
  • B. BRAUN MELSUNGEN AG
  • BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
  • INTEGRA LIFESCIENCES
  • ORGANOGENESIS HOLDINGS
  • SID MARTIN BIOTECH (AXOGEN)
  • SMITH & NEPHEW PLC. (OSIRIS THERAPEUTICS)
  • TISSUETECH INC.
  • VERICEL CORPORATION
  • ZIMMER BIOMET HOLDINGS, INC.
目錄
Product Code: A03976

Title:
Tissue Engineering Market by Type (Synthetic Scaffold Material, Biologically Derived Scaffold Material, and Others), Application (Orthopedics & Musculoskeletal, Neurology, Cardiovascular, Skin & Integumentary, Dental, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global tissue engineering market was valued at $2,374 million in 2019, and is projected to reach $6,815 million by 2027, registering a CAGR of 14.2% from 2020 to 2027.

Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences toward development of biological substitutes that restore, maintain, or improve tissue function. In addition, for this process, cells and biomolecules are combined with scaffolds. Scaffold is an artificial or natural structure that mimics real organs.

The tissue engineering market is anticipated to grow significantly during the forecast period, owing to increase in prevalence of chronic diseases & trauma emergencies, rise in awareness related to tissue engineering, and potential pipeline products. Furthermore, growth in number of R&D activities with rise in awareness of tissue engineering in emerging economies are expected to support the market growth. Developed nations have adopted technological advancements in tissue engineering and regenerative medicine sectors, which help in expansion of the global market. In addition, increase in focus of key players on tissue engineering based therapies are expected to enhance the tissue engineering market growth during the forecast period. However, stringent government regulations and high cost of treatment are estimated to hamper growth of the market.

The global tissue engineering market is segmented into type, application, and region. On the basis of type, the market is categorized into synthetic scaffold material, biologically derived scaffold material, and others. The synthetic scaffold material segment is further categorized into synthetic polymer and others. The biologically derived scaffold material segment is bifurcated into collagen and others. On the basis of application, the market is segregated into orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product

  • Synthetic Scaffold Material
  • Synthetic Polymer
  • Others
  • Biologically Derived Scaffold Material
  • Collagen
  • Others
  • Others

By Application

  • Orthopedics & Musculoskeletal
  • Neurology
  • Cardiovascular
  • Skin & Integumentary
  • Dental
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East and Africa
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • AbbVie Inc. (Allergen Plc.)
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company (C. R. BARD, INC.)
  • Integra LifeSciences
  • Organogenesis Holdings
  • Sid Martin Biotech (Axogen)
  • Smith & Nephew Plc. (Osiris Therapeutics)
  • TissueTech Inc.
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • Modex Therapeutics
  • Biotime Inc
  • Sanofi (Genzyme)

TABLE OF CONTENTS

Chapter 1:Introduction

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

Chapter 2:Executive Summary

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

Chapter 3:Market landscape

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five force analysis
  • 3.4.Top player positioning, 2019
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in need for tissue engineering in organ transplantation
      • 3.5.1.2.Advancements in medical equipment technologies
      • 3.5.1.3.Increase in prevalence of chronic diseases and trauma emergencies
    • 3.5.2.Restraint
      • 3.5.2.1.High cost associated with tissue engineered products
      • 3.5.2.2.Hurdles associated with tissue engineering
    • 3.5.3.Opportunity
      • 3.5.3.1.Growth opportunities in emerging markets
    • 3.5.4.Impact analysis
  • 3.6.Market information on kidney and liver tissue engineering
  • 3.7.Market overview: product segment
    • 3.7.1.Cell Therapy
    • 3.7.2.Gene Therapy
    • 3.7.3.Small molecules and biologics
  • 3.8.COVID-19 impact analysis on tissue engineering market

Chapter 4:Tissue Engineering MARKET, BY type

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Synthetic scaffold material
    • 4.2.1.Key market trends growth factors and opportunities
    • 4.2.2.Market size and forecast, by type
      • 4.2.2.1.Synthetic polymer
      • 4.2.2.2.Others
    • 4.2.3.Market size and forecast, by region
    • 4.2.4.Market analysis, by country
  • 4.3.Biologically derived scaffold materials
    • 4.3.1.Key market trends growth factors and opportunities
    • 4.3.2.Market size and forecast, by type
      • 4.3.2.1.Collagen
      • 4.3.2.2.Others
    • 4.3.3.Market size and forecast, by region
    • 4.3.4.Market analysis, by country
  • 4.4.Others
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country

Chapter 5:Tissue Engineering MARKET, BY Application

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Orthopedics & musculoskeletal
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Neurology
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Cardiovascular
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Skin & integumentary
    • 5.5.1.Market size and forecast, by region
    • 5.5.2.Market analysis, by country
  • 5.6.Dental
    • 5.6.1.Market size and forecast, by region
    • 5.6.2.Market analysis, by country
  • 5.7.Others
    • 5.7.1.Market size and forecast, by region
    • 5.7.2.Market analysis, by country

Chapter 6:Tissue Engineering MARKET, BY Region

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key market trends, key growth factors and opportunities
    • 6.2.2.Market size and forecast, by country
      • 6.2.2.1.U.S.
      • 6.2.2.1.1.U.S. tissue engineering market, by type
      • 6.2.2.1.2.U.S. tissue engineering market, by application
      • 6.2.2.2.Canada
      • 6.2.2.2.1.Canada tissue engineering market, by type
      • 6.2.2.2.2.Canada tissue engineering market, by application
      • 6.2.2.3.Mexico
      • 6.2.2.3.1.Mexico tissue engineering market, by type
      • 6.2.2.3.2.Mexico tissue engineering market, by application
    • 6.2.3.North America market size and forecast, by type
    • 6.2.4.North America market size and forecast, by application
  • 6.3.Europe
    • 6.3.1.Key market trends, growth factors, and opportunities
    • 6.3.2.Market size and forecast, by country
      • 6.3.2.1.Germany
      • 6.3.2.1.1.Germany tissue engineering market, by type
      • 6.3.2.1.2.Germany tissue engineering market, by application
      • 6.3.2.2.France
      • 6.3.2.2.1.France tissue engineering market, by type
      • 6.3.2.2.2.France tissue engineering market, by application
      • 6.3.2.3.UK
      • 6.3.2.3.1.UK tissue engineering market, by type
      • 6.3.2.3.2.UK tissue engineering market, by application
      • 6.3.2.4.Italy
      • 6.3.2.4.1.Italy tissue engineering market, by type
      • 6.3.2.4.2.Italy tissue engineering market, by application
      • 6.3.2.5.Spain
      • 6.3.2.5.1.Spain tissue engineering market, by type
      • 6.3.2.5.2.Spain tissue engineering market, by application
      • 6.3.2.6.Rest of Europe
      • 6.3.2.6.1.Rest of Europe tissue engineering market, by type
      • 6.3.2.6.2.Rest of Europe tissue engineering market, by application
    • 6.3.3.Europe market size and forecast, by type
    • 6.3.4.Europe market size and forecast, by application
  • 6.4.Asia-pacific
    • 6.4.1.Key market trends, growth factors, and opportunities
    • 6.4.2.Market size and forecast
      • 6.4.2.1.Japan
      • 6.4.2.1.1.Japan tissue engineering market, by type
      • 6.4.2.1.2.Japan tissue engineering market, by application
      • 6.4.2.2.China
      • 6.4.2.2.1.China tissue engineering market, by type
      • 6.4.2.2.2.China tissue engineering market, by application
      • 6.4.2.3.Australia
      • 6.4.2.3.1.Australia tissue engineering market, by type
      • 6.4.2.3.2.Australia tissue engineering market, by application
      • 6.4.2.4.India
      • 6.4.2.4.1.India tissue engineering market, by type
      • 6.4.2.4.2.India tissue engineering market, by application
      • 6.4.2.5.South Korea
      • 6.4.2.5.1.South Korea tissue engineering market, by type
      • 6.4.2.5.2.South Korea tissue engineering market, by application
      • 6.4.2.6.Rest of Asia-Pacific market size and forecast
      • 6.4.2.6.1.Rest of Asia-Pacific tissue engineering market, by type
      • 6.4.2.6.2.Rest of Asia-Pacific tissue engineering market, by application
    • 6.4.3.Asia-pacific market size and forecast, by type
    • 6.4.4.Asia-pacific market size and forecast, by application
  • 6.5.LAMEA
    • 6.5.1.Key market trends, growth factors, and opportunities
    • 6.5.2.Market size and forecast
      • 6.5.2.1.Latin America
      • 6.5.2.1.1.Latin America tissue engineering market, by type
      • 6.5.2.1.2.Latin America tissue engineering market, by application
      • 6.5.2.2.Middle East & Africa
      • 6.5.2.2.1.Middle East & Africa tissue engineering market, by type
      • 6.5.2.2.2.Middle East & Africa tissue engineering market, by application
    • 6.5.3.LAMEA market size and forecast, by type
    • 6.5.4.LAMEA market size and forecast, by application

Chapter 7:Company profiles

  • 7.1.ABBVIE INC. (ALLERGEN PLC.)
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Operating business segments
    • 7.1.4.Product portfolio
    • 7.1.5.Business performance
    • 7.1.6.Key strategic moves and developments
  • 7.2.B. BRAUN MELSUNGEN AG
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Operating business segments
    • 7.2.4.Product portfolio
    • 7.2.5.Business performance
  • 7.3.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Operating business segments
    • 7.3.4.Product portfolio
    • 7.3.5.Business performance
    • 7.3.6.Key strategic moves and developments
  • 7.4.INTEGRA LIFESCIENCES
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segments
    • 7.4.4.Product portfolio
    • 7.4.5.Business performance
    • 7.4.6.Key strategic moves and developments
  • 7.5.ORGANOGENESIS HOLDINGS
    • 7.5.1.Company overview
    • 7.5.2.Company snapshot
    • 7.5.3.Operating business segments
    • 7.5.4.Product portfolio
    • 7.5.5.Business performance
    • 7.5.6.Key strategic moves and developments
  • 7.6.SID MARTIN BIOTECH (AXOGEN)
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Product portfolio
    • 7.6.5.Business performance
    • 7.6.6.Key strategic moves and developments
  • 7.7.SMITH & NEPHEW PLC. (OSIRIS THERAPEUTICS)
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Operating business segments
    • 7.7.4.Product portfolio
    • 7.7.5.Business performance
    • 7.7.6.Key strategic moves and developments
  • 7.8.TISSUETECH INC.
    • 7.8.1.Company overview
    • 7.8.2.Company snapshot
    • 7.8.3.Operating business segments
    • 7.8.4.Product portfolio
  • 7.9.VERICEL CORPORATION
    • 7.9.1.Company overview
    • 7.9.2.Company snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Product portfolio
    • 7.9.5.Business performance.
    • 7.9.6.Key strategic moves and developments
  • 7.10.ZIMMER BIOMET HOLDINGS, INC.
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating business segments
    • 7.10.4.Product portfolio
    • 7.10.5.BUSINESS PERFORMANCE

LIST OF TABLES

  • TABLE 01.GLOBAL TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 02.GLOBAL SYNTHETIC SCAFFOLD MATERIAL MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 03.SYNTHETIC SCAFFOLD MATERIAL TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 04.GLOBAL BIOLOGICALLY DERIVED SCAFFOLD MATERIAL MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 05.BIOLOGICALLY DERIVED SCAFFOLD MATERIALS TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 06.OTHERS TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 07.GLOBAL TISSUE ENGINEERING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 08.ORTHOPEDICS & MUSCULOSKELETAL TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.NEUROLOGY TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.CARDIOVASCULAR TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.SKIN & INTEGUMENTARY TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.DENTAL TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 13.OTHERS TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.GLOBAL TISSUE ENGINEERING MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.NORTH AMERICA TISSUE ENGINEERING MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 16.U.S. TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 17.U.S. TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 18.CANADA TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 19.CANADA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 20.MEXICO TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 21.MEXICO TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 22.NORTH AMERICA TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 23.NORTH AMERICA TISSUE ENGINEERING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 24.EUROPE TISSUE ENGINEERING MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 25.GERMANY TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 26.GERMANY TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 27.FRANCE TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 28.FRANCE TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 29.UK TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 30.UK TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 31.ITALY TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 32.ITALY TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 33.SPAIN TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 34.SPAIN TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 35.REST OF EUROPE TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 36.REST OF EUROPE TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 37.EUROPE TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 38.EUROPE TISSUE ENGINEERING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 39.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 40.JAPAN TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 41.JAPAN TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 42.CHINA TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 43.CHINA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 44.AUSTRALIA TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 45.AUSTRALIA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 46.INDIA TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 47.INDIA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 48.SOUTH KOREA TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 49.SOUTH KOREA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 50.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 51.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 52.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 53.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 54.LAMEA TISSUE ENGINEERING MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 55.LATIN AMERICA TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 56.LATIN AMERICA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 57.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 58.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019-2027 ($MILLION)
  • TABLE 59.LAMEA TISSUE ENGINEERING MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 60.LAMEA TISSUE ENGINEERING MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 61.ABBVIE: COMPANY SNAPSHOT
  • TABLE 62.ABBVIE: OERATING SEGMENT
  • TABLE 63.ABBVIE: PRODUCT PORTFOLIO
  • TABLE 64.ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 65.B BRAUN: COMPANY SNAPSHOT
  • TABLE 66.B BRAUN: PRODUCT SEGMENTS
  • TABLE 67.B BRAUN: PRODUCT PORTFOLIO
  • TABLE 68.BD: COMPANY SNAPSHOT
  • TABLE 69.BD: OERATING SEGMENT
  • TABLE 70.BD: PRODUCT PORTFOLIO
  • TABLE 71.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 72.INTEGRA: COMPANY SNAPSHOT
  • TABLE 73.INTEGRA: OPERATING BUSINESS SEGMENTS
  • TABLE 74.INTEGRA: PRODUCT PORTFOLIO
  • TABLE 75.ORGANOGENESIS: COMPANY SNAPSHOT
  • TABLE 76.ORGANOGENESIS: OPERATING SEGMENTS
  • TABLE 77.ORGANOGENESIS: PRODUCT PORTFOLIO
  • TABLE 78.AXOGEN: COMPANY SNAPSHOT
  • TABLE 79.AXOGEN: OPERATING SEGMENTS
  • TABLE 80.AXOGEN: PRODUCT PORTFOLIO
  • TABLE 81.AXOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82.SMITH & NEPHEW: COMPANY SNAPSHOT
  • TABLE 83.SMITH & NEPHEW: OPERATING SEGMENTS
  • TABLE 84.SMITH & NEPHEW: PRODUCT PORTFOLIO
  • TABLE 85.TISSUETECH: COMPANY SNAPSHOT
  • TABLE 86.TISSUETECH: OPERATING BUSINESS SEGMENTS
  • TABLE 87.HOLOGIC: PRODUCT PORTFOLIO
  • TABLE 88.VERICEL: COMPANY SNAPSHOT
  • TABLE 89.VERICEL: OPERATING SEGMENTS
  • TABLE 90.VERICEL: PRODUCT PORTFOLIO
  • TABLE 91.ZIMMER BIOMET: COMPANY SNAPSHOT
  • TABLE 92.ZIMMER BIOMET: OPERATING SEGMENTS
  • TABLE 93.ZIMMER BIOMET: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.TISSUE ENGINEERING MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017-2020
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2020
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017-2020
  • FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.LOW THREAT OF SUBSTITUTES
  • FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 10.HIGH INTENSITY OF RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2019
  • FIGURE 12.IMPACT ANALYSIS:
  • FIGURE 13.SYNTHETIC POLYMER MARKET, 2019 - 2027 ($MILLION)
  • FIGURE 14.OTHERS MARKET, 2019 - 2027 ($MILLION)
  • FIGURE 15.COMPARATIVE ANALYSIS SYNTHETIC SCAFFOLD MATERIAL TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 16.COLLAGEN MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 17.OTHERS MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS BIOLOGICALLY DERIVED SCAFFOLD MATERIALS TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 19.COMPARATIVE ANALYSIS OTHERS TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 20.COMPARATIVE ANALYSIS ORTHOPEDICS & MUSCULOSKELETAL TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 21.COMPARATIVE ANALYSIS NEUROLOGY TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 22.COMPARATIVE ANALYSIS CARDIOVASCULAR TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 23.COMPARATIVE ANALYSIS SKIN & INTEGUMENTARY TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 24.COMPARATIVE ANALYSIS DENTAL TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 25.COMPARATIVE ANALYSIS OTHERS TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 26.U.S. TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 27.CANADA TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 28.MEXICO TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 29.GERMANY TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 30.FRANCE TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 31.UK TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 32.ITALY TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 33.SPAIN TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 34.REST OF EUROPE TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 35.JAPAN TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 36.CHINA TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 37.AUSTRALIA TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 38.INDIA TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 39.SOUTH KOREA TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 40.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 41.LATIN AMERICA TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 42.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, 2019-2027 ($MILLION)
  • FIGURE 43.ABBVIE: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 44.ABBVIE: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 45.B BRAUN: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 46.B BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 47.B BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 48.BD: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 49.BD: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 50.BD: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 51.INTEGRA: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 52.INTEGRA: REVENUE SHARE, BY SEGMENT, 2019(%)
  • FIGURE 53.INTEGRA: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 54.ORGANOGENESIS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 55.ORGANOGENESIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 56.AXOGEN: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 57.SMITH & NEPHEW: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 58.SMITH & NEPHEW: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 59.SMITH & NEPHEW: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 60.VERICEL: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 61.VERICEL: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 62.ZIMMER BIOMET: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 63.ZIMMER BIOMET: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 64.ZIMMER BIOMET: REVENUE SHARE, BY REGION, 2019(%)